Jennifer Lowery
Family Medicine · Pontotoc, MSNPI 1376777201
Payments from drug & device makers
Across 111 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$342
- Otsuka America Pharmaceutical, Inc.$256
- Novo Nordisk$224
- Pfizer$148
- AstraZeneca$140
- AbbVie$126
- plus $569 from 17 others
What the payments were for
- Food & beverage$1,78999%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 25 | $342 |
| Otsuka America Pharmaceutical, Inc. | 11 | $256 |
| Novo Nordisk | 14 | $224 |
| Pfizer | 10 | $148 |
| AstraZeneca | 10 | $140 |
| AbbVie(2 entities) | 7 | $126 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| Lilly USA, LLC | 5 | $80 |
| Johnson & Johnson | 4 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 1 | $26 |
| GSK | 2 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Nevro Corp. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Novartis | 1 | $14 |
How this compares
$1,805 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 422 | $188,774 |
| OzempicSemaglutide | 60 | $117,073 |
| JardianceEmpagliflozin | 128 | $102,697 |
| FarxigaDapagliflozin Propanediol | 93 | $93,520 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 95 | $90,545 |
| TrulicityDulaglutide | 59 | $84,342 |
| JanuviaSitagliptin Phosphate | 54 | $72,383 |
| LinzessLinaclotide | 131 | $67,979 |
| MounjaroTirzepatide | 39 | $58,916 |
| Tresiba Flextouch U-200Insulin Degludec | 49 | $46,283 |
| Tresiba Flextouch U-100Insulin Degludec | 54 | $35,313 |
| MyrbetriqMirabegron | 77 | $35,054 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 47 | $30,667 |
| XareltoRivaroxaban | 41 | $27,881 |
| TrintellixVortioxetine Hydrobromide | 30 | $23,545 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $148 | $188,774422 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $80 | $143,25798 claims |
| Boehringer IngelheimJardiance, Tradjenta | $20 | $121,842145 claims |
| Novo NordiskOzempic | $224 | $117,07360 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $24 | $103,152124 claims |
| AstraZenecaFarxiga, Symbicort | $140 | $98,992118 claims |
| AbbVieLinzess, Restasis, Savella, Synthroid | $126 | $94,991205 claims |
| Astellas Pharma US IncMyrbetriq | $22 | $35,05477 claims |
| Johnson & JohnsonXarelto, Invokana | $64 | $33,80965 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $39 | $23,54530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Pontotoc
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.